Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00416429
What this trial is testing

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 456
Testing effectiveness (Phase 2)Looking for participantsNCT06781567
What this trial is testing

Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic CarcinomaHead and Neck Cancer
HitGen Inc. 140
Not applicableNot Yet RecruitingNCT07478705
What this trial is testing

Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging

Who this might be right for
Triple Negative Breast CancerSurveillanceRecurrence+1 more
Sunnybrook Health Sciences Centre 30
Not applicableStudy completedNCT01445145
What this trial is testing

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT04672772
What this trial is testing

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 531
Testing effectiveness (Phase 2)Ended earlyNCT02508077
What this trial is testing

FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colorectal CarcinomaStage IVA Colorectal CancerStage IVB Colorectal Cancer
City of Hope Medical Center 1
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Testing effectiveness (Phase 2)Study completedNCT00003892
What this trial is testing

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
NCIC Clinical Trials Group 22
Testing effectiveness (Phase 2)Study completedNCT04380805
What this trial is testing

AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Who this might be right for
Recurrent Cervical CancerMetastatic Cervical Cancer
Akeso 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813836
What this trial is testing

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University College, London 63
Testing effectiveness (Phase 2)Looking for participantsNCT02029001
What this trial is testing

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Who this might be right for
Malignant Solid Neoplasms
Centre Leon Berard 900
Not applicableStudy completedNCT00277082
What this trial is testing

Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung

Who this might be right for
Corpus UteriLung Cancer
University of New Mexico 24
Early research (Phase 1)Study completedNCT00101179
What this trial is testing

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+5 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT00058487
What this trial is testing

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00551421
What this trial is testing

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00811135
What this trial is testing

Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Study completedNCT01231399
What this trial is testing

Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT07045311
What this trial is testing

JS207 Combination Therapy in Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 80
Next Page